Rephonic
Artwork for The BioCentury Show

The BioCentury Show

BioCentury
Biosecure Act
Novartis
Inflation Reduction Act
Biotechnology
Drug Pricing
Scemblix
Gene Therapy
Biotech
Reme Bruttenheib
Chronic Myeloid Leukemia
Pediatric Oncology
Regulatory Framework
Life Sciences
FDA
Clinical Trials
Josh Hardy
Biotech Financing
U.s.-China Relations
Alzheimer's
Biopharma Industry

Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine.

Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues.

The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how scien... more

PublishesTwice monthlyEpisodes45Foundeda year ago
Number of ListenersCategories
BusinessLife SciencesScience

Listen to this Podcast

Artwork for The BioCentury Show

Latest Episodes

The frenzy among Western companies to access China’s biotechnology innovation is remaking the landscape for cross-border dealmaking, with assets becoming more expensive and partnerships earlier and broader than ever before. That’s being driven by exc... more

YouTube

President Donald Trump’s demands for “most favored nation” drug pricing presents the biopharma industry with an immense public policy challenge. Drug companies are convinced that meeting the president’s demand to reduce U.S. prices to levels below th... more

YouTube

If you could redesign FDA from the ground up, what would it look like? That’s the fundamental question underlying the 2025 BioCentury Back to School essay, authored by BioCentury Washington Editor Steve Usdin, who has been a leading voice on regulati... more

YouTube

A new head at MHRA, a streamlined government life sciences strategy, and a more sophisticated innovation ecosystem have Annalisa Jenkins optimistic about the future of U.K. biotech — and its potential to carve out a stronger global role.

On The BioCe... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

James Li
Venture partner at Frazier Life Sciences with over 30 years of biotech experience as an investor and executive.
Frazier Life Sciences
Episode: Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
John Lepore
CEO of Profound Therapeutics and a CEO partner at Flagship Pioneering, cardiologist, and internist.
Profound Therapeutics
Episode: Ep. 90 – Inside Biopharma Dealmaking: ProFound CEO John Lepore on Knowing What Partners Want
Gillian Wollett
Head of regulatory strategy and policy at Samsung Bioepis
Samsung Bioepis
Episode: Ep. 89 - Delivering on the biosimilars promise, a conversation with Gillian Woollett
Adam Steensberg
President and CEO of Zealand Pharma
Zealand Pharma
Episode: Ep. 88 – From Satiety to Muscle: Zealand CEO Steensberg on Amylin’s Edge in Obesity
SJ Lee
CEO of Orum Therapeutics
Orum Therapeutics
Episode: Ep. 87 – Korea’s Biotech Playbook: Orum CEO SJ Lee on Going Global and Creating Novel Therapies
Juho Jalkanen
Founder and CEO of Finnish Biotech, Faron
Faron Pharmaceuticals
Episode: Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise
Jorge Santos da Silva
CEO of Moonlake Immunotherapeutics, a Swiss biotech company focused on immunologic diseases.
Moonlake Immunotherapeutics
Episode: Ep. 84 – Leadership Amid Turmoil: Moonlake CEO Jorge Santos Da Silva
Zahid Moneer
Senior Managing Director, Investment Banking at BNP Paribas
BNP Paribas
Episode: Ep. 79 - BNP Paribas’ Moneer on Biotech’s Bull Case: M&A, PE, and Market Recovery
Simeon George
CEO and managing partner of the venture firm SR One.
SR One
Episode: Ep. 78 - Biotech’s New Normal: SR One’s Simeon George on Adapting to Market Constraints

Hosts

Steve Ustin
Washington editor at BioCentury, provides insights and discussions on biotech and healthcare policies, focusing on critical public health issues.
Simone Fishburn
Editor in chief at BioCentury, engages in discussions with industry leaders regarding advances in biopharma and healthcare.
Jeff Cranmer
Executive Editor at BioCentury, contributes to discussions with a focus on healthcare innovations and marketplace analysis.

Reviews

4.7 out of 5 stars from 23 ratings
  • Wow

    Insightful and full of great info every time! Thx!

    Apple Podcasts
    5
    Surfrider182
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Insightful and full of great info every time!
The unique perspectives from industry leaders are invaluable.
Provides a deep understanding of emerging healthcare issues.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
Q: How are you seeing deal making changing in China?
Li details the shift from Chinese companies licensing US products to engaging in substantial deals, with increasing activity from multinational firms like Merck and Pfizer.
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
Q: Can you bring them up to speed on key inflection points of China's biotech?
Li outlines regulatory reforms starting in 2014-2015 and the subsequent emergence of biotech companies thriving under these new regulations.
Ep. 89 - Delivering on the biosimilars promise, a conversation with Gillian Woollett
Q: What does interchangeability mean in the context of biosimilars?
Interchangeability refers to a designation that allows pharmacists to substitute biosimilars for original biologics without a new prescription, but technically, every biosimilar is interchangeable in practice regardless of designation.
Ep. 89 - Delivering on the biosimilars promise, a conversation with Gillian Woollett
Q: Can you explain why large scale efficacy trials aren't necessary for biosimilars?
The product's comparability can be demonstrated through advanced analytics, showing that a product is the same as a pre-manufacturing change product without needing clinical efficacy studies.
Ep. 87 – Korea’s Biotech Playbook: Orum CEO SJ Lee on Going Global and Creating Novel Therapies
Q: Are there unique opportunities in the Korean biotech space?
SJ mentions that Korean biotech is often founder-driven with unique ideas, and emphasizes the importance of looking for innovative platforms that may not be found elsewhere.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The BioCentury Show

What is The BioCentury Show about and what kind of topics does it cover?

This podcast features in-depth discussions with prominent figures in the biopharmaceutical and biotechnology sectors. Topics frequently covered include drug pricing, regulatory policies, and the development of innovative therapies. Episodes feature industry leaders such as CEOs, editors, and policymakers who share insights on urgent public health challenges and the intersection of science and medicine. The unique format emphasizes face-to-face dialogue, creating an engaging atmosphere for listeners interested in the evolution of healthcare and biopharmaceutical advancements.

Where can I find podcast stats for The BioCentury Show?

Rephonic provides a wide range of podcast stats for The BioCentury Show. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The BioCentury Show and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The BioCentury Show get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The BioCentury Show, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The BioCentury Show?

Rephonic provides comprehensive predictive audience data for The BioCentury Show, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The BioCentury Show have?

To see how many followers or subscribers The BioCentury Show has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The BioCentury Show?

These podcasts share a similar audience with The BioCentury Show:

1. BioCentury This Week
2. Biotech Hangout
3. The Readout Loud
4. Business Of Biotech
5. Biotech 2050 Podcast

How many episodes of The BioCentury Show are there?

The BioCentury Show launched a year ago and published 45 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The BioCentury Show?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The BioCentury Show?

Rephonic pulls ratings and reviews for The BioCentury Show from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The BioCentury Show?

Rephonic provides full transcripts for episodes of The BioCentury Show. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The BioCentury Show?

Recent guests on The BioCentury Show include:

1. James Li
2. John Lepore
3. Gillian Wollett
4. Adam Steensberg
5. SJ Lee
6. Juho Jalkanen
7. Jorge Santos da Silva
8. Zahid Moneer

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days